Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Aricept (donepezil)
- brigatinib
Interactions between your drugs
donepezil brigatinib
Applies to: Aricept (donepezil), brigatinib
Brigatinib and donepezil may have additive effects in lowering your heart rate. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart beat. These side effects are most likely to be seen at the beginning of treatment, following a dose increase, or when treatment is restarted after an interruption. Let your doctor know if you develop these symptoms and they do not go away or they become troublesome. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
brigatinib food
Applies to: brigatinib
Grapefruit juice can increase the blood levels of brigatinib. This may increase side effects such as nausea, vomiting, diarrhea, high blood pressure, high blood sugar, slow heart rate, visual disturbances, anemia, and infections. You should avoid consuming grapefruit and grapefruit juice during treatment with brigatinib. Seek medical attention if you develop paleness, fatigue, dizziness, fainting, fever, chills, diarrhea, sore throat, muscle aches, shortness of breath, blood in phlegm, weight loss, red or inflamed skin, body sores, or pain and burning during urination. Talk to your healthcare provider if you have any questions or concerns.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Kisunla
Kisunla (donanemab) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Donanemab
Donanemab (Kisunla) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Vitamin e
Vitamin E is an antioxidant that occurs naturally in some foods and is used to treat or prevent ...
Rivastigmine
Rivastigmine is used for alzheimer's disease, lewy body dementia, parkinson's disease
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.